Updated: House panel: Mylan CEO disguised profits in EpiPen testimony

WASHINGTON — Leaders of the House Oversight Committee want EpiPen maker Mylan to explain why the company’s CEO failed to tell Congress that profit rates the company claimed for the life-saving EpiPen were calculated after taxes. Mylan CEO Heather Bresch repeatedly told the panel last month that Mylan made just $50 in profit for EpiPens […]